Health Care | Health Care Equipment & Services | Health Care Equipment & Supplies | Health Care Equipment
NASDAQ | Common Stock
Akers Biosciences, Inc. focuses on the development of a vaccine candidate against SARS-CoV-2, a coronavirus causing a pandemic.
It has a collaboration agreement with Premas Biotech PVT Ltd. The company was incorporated in 1989 and is headquartered in New York, New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 31, 21 | -0.19 Increased by +88.24% | - |
| Dec 31, 20 | -0.24 Increased by +71.04% | - |
| Sep 30, 20 | -0.38 Increased by +74.76% | - |
| Jun 30, 20 | -0.69 Increased by +52.95% | - |
| Mar 31, 20 | -1.59 Increased by +6.31% | - |
| Dec 31, 19 | -0.82 Increased by +87.24% | - |
| Sep 30, 19 | -1.51 Increased by +75.89% | - |
| Jun 30, 19 | -1.47 Increased by +65.51% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 20 | 0.00 Decreased by -100.00% | -17.58 M Decreased by -1.21 K% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 20 | 0.00 Decreased by -100.00% | -7.13 M Decreased by -751.49% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 20 | -1.89 K Decreased by -100.41% | -3.63 M Decreased by -356.43% | Increased by +192.17 K% Increased by +112.40 K% |
| Mar 31, 20 | 363.51 K Decreased by -40.61% | -3.54 M Decreased by -285.90% | Decreased by -973.42% Decreased by -549.82% |
| Dec 31, 19 | 79.58 K Decreased by -71.52% | -1.34 M Increased by +65.10% | Decreased by -1.68 K% Decreased by -22.53% |
| Sep 30, 19 | 420.81 K Decreased by -24.46% | -837.03 K Increased by +72.86% | Decreased by -198.91% Increased by +64.07% |
| Jun 30, 19 | 464.51 K Decreased by -11.79% | -794.89 K Increased by +61.55% | Decreased by -171.12% Increased by +56.41% |
| Mar 31, 19 | 612.12 K Increased by +102.37% | -916.96 K Increased by +50.70% | Decreased by -149.80% Increased by +75.64% |